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While the Complement protein system in human milk is well characterised, there is little information
on its presence and activity in bovine milk. Complement forms part of the innate immune system,
hence the importance of its contribution during milk ingestion to the overall defences of the
neonate. A bactericidal sequestration assay, featuring a Complement sensitive strain, Escherichia
coli 0111, originally used to characterise Complement activity in human milk was successfully
applied to freshly drawn bovine milk samples, thus, providing an opportunity to compare
Complement activities in both human and bovine milks. Although not identical in response, the
levels of Complement activity in bovine milk were found to be closely comparable with that of
human milk. Differential counts of Esch. coli 0111 after 2 h incubation were 6·20 and 6·06 log
CFU/ml, for raw bovine and human milks, respectively – the lower value representing a stronger
Complement response. Exposing bovine milk to a range of thermal treatments e.g. 42, 45, 65, 72,
85 or 95 °C for 10 min, progressively inhibited Complement activity by increasing temperature,
thus confirming the heat labile nature of this immune protein system. Low level Complement activity
was found, however, in 65 and 72 °C heat treated samples and in retailed pasteurised milk which
highlights the outer limit to which high temperature, short time (HTST) industrial thermal processes
should be applied if retention of activity is a priority. Concentration of Complement in the fat phase
was evident following cream separation, and this was also reflected in the further loss of activity
recorded in low fat variants of retailed pasteurised milk. Laboratory-based churning of the cream
during simulated buttermaking generated an aqueous (buttermilk) phase with higher levels of
Complement activity than the fat phase, thus pointing to a likely association with the milk fat
globule membrane (MFGM) layer.
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As well as being a source of essential nutrients for optimum
growth and development, milk provides the neonate with
protective elements to support survival of the new-born
(Hanssen, 1924; Van Hooijdonk et al. 2000). While the bac-
teriostatic qualities of milk were recognised as far back as
1924 (Hanssen, 1924) research over the years has focussed
on the characterisation of its antimicrobial components such
as lactoferrin, lactoperoxidase, lysozyme, peptides derived
in vivo during digestion and sialyl-containing oligosacchar-
ides. However, less consideration appears to have been
given to the role of another line of defence i.e. the extent
to which the innate immune system of the lactating
mammal is manifested in its milk secretions. Innate immun-
ity with its physical barriers and cellular components
provides non-specific protection as a first line of defence
(Ricklin & Lambris, 2007) which is distinguishable from
that of the adaptive immune system that typically responds
to specific pathogenic challenge (Galyean et al. 1999).
Within innate immunity, Complement consists of serum
and membrane proteins which circulate as inactive precur-
sors in the blood system. The triggering of these precursors
initiates a cascade of protein cleavages which culminates
in the amplification of a cell-killing membrane attack
complex (Oviedo-Boyso et al. 2007). Though initiated by
different mechanisms, all three established Complement
pathways i.e. classical, alternative and mannan-binding*For correspondence; e-mail: phil.kelly@teagasc.ie
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lectin (MBL) converge at the point when complement com-
ponent C3 becomes active (Abbas et al. 1994). The classical
pathway commences with immune complexation by IgG
or IgM to pathogens or foreign antigens, the alternative
pathway is triggered by either carbohydrates, lipids or pro-
teins found on the surface of foreign microbes or cells in
the body, and the MBL pathway is activated when either
MBL or Ficolin binds to the surface of pathogens due to
carbohydrate moieties (Sarma & Ward, 2011).
Efforts to date at addressing the presence and role of
Complement in human milk (Ogundele, 1998) also lend
support to the view that such innate immune components
migrate from the circulatory system in the mammary into
the secreted milk. However, little is known about its activity
in bovine milk and its presence is not even recognised in the
recent revision (6th) of the nomenclature of the proteins in
cows’ milk (Farrell et al. 2004). Lack of suitable assays
may have been a contributing factor to this paucity of infor-
mation. Gradually, the bactericidal sequestration assay-
based analytical approach was adapted initially to help
identify bactericidal and haemolytic activity of bovine col-
ostrum (Reiter & Brock, 1975), bovine mastitic milk
(Rainard & Caffin, 1984) and human milk (Ogundele,
1998). The uniqueness of the bactericidal sequestration
assay in this case is that growth of a specific pathogenic
bacterial strain i.e. Escherichia coli 0111 is sensitive to the
presence of Complement, thus exploiting the extent of
growth inactivation as an indirect measure of Complement
activity present.
Thus, an objective of this study was to adapt and apply the
bactericidal sequestration assay used by Ogundele (1998) to
establish the level of Complement activity in fresh bovine
milk and its comparability with that of human breast milk.
A further objective was to evaluate the extent to how such
activity may be affected by typical milk processes such as
heating and cream separation. This interest was taking
place against a backdropofwhere advances in the ‘humanisa-
tion’ of bovine milk for use as infant feed formula requires
a deeper understanding of the biological comparability
between both bovine and human breast milk Complement,
so thatappropriate strategiesmaybedesigned for itsprotection
in freshly secreted bovine milk during the course of dairy
manufacturing processes.
Material and methods
Sample preparation
Milk samples. Fresh whole bovine milk was collected from
theMoorepark Dairy Production Centre (MDPC) farm on the
day of testing. The somatic cell counts (SCC) of the freshly
collected milk was determined using Bentley Somacount
300® (Bentley Instruments Inc., Chaska MN, USA), SCC of
<200 000 cells/ml was required for use of the milk.
Fresh commercial products including cream, full fat milk
and low fat milk were purchased from local supermarkets on
the day of testing.
Human milk was collected from the Western Health and
Social Care Trust (Glenshane Road, Londonderry BT47 6SB,
United Kingdom) and was stored in aliquots at −80 °C until
required.
Control preparation. Freshly collected raw milk was heat
treated at 56 °C for 30 min to ensure complete inactivation
of the Complement protein (Korhonen et al. 2000a). All
samples were screened using the International Dairy
Federation (IDF) methods (IDF, 2004, 2013) and also the
milks were streaked on Nutrient and Luria Bertani agar.
Effect of heat treatment. Individual milk samples were
exposed to a range of temperatures: 42, 45, 65, 72, 85 and
95 °Cwith 10 min holding time before bactericidal sequestra-
tion assay in order to determine the effect of heating on
Complement activity (Korhonen et al. 2000b). Milk samples
were heat-treated using Hettich Elbanton special products
oil bath (Hettich Benelux B.V., De Aaldor 9–4191 PC
Geldermalsen, Netherlands) with rocking arm to ensure
uniform heat treatment throughout the samples. A control
sample generated by heating at 56 °C for 30 min was used
as reference for complete Complement inactivation.
Milk samples separation and washing. An Armfield disc
bowl centrifuge (Armfield, Ringwood, UK) was used to gen-
erate cream samples (approximately 40% fat) and skimmed
milk (approximately 1% fat) from the fresh raw milk. The
cream was then stored at 4 °C overnight and the following
morning a Kenwood Chef food mixer (Model KM220,
Harvant, Hants, UK) was used to disrupt the cream emulsion
resulting in the production of butter. From this buttermilk
was released and was filtered through glass wool to
remove butter grains. Human milk was thawed overnight at
4 °C. This was then separated by centrifugation at 2000 g for
15 min at 4 °C (Patton & Huston, 1986) in order to separate
the fat fraction.
Washed buttermilk was prepared using the Armfield disc
bowl centrifuge however, an additional step was incorpo-
rated whereby the cream was suspended in sterile distilled
water and held at 37 °C for 1 h to wash the buttermilk.
The separation procedure was repeated (Armfield disc
bowl centrifuge) and cream collected. This step was
repeated twice more.
Bacterial strain
Escherichia coli 0111 (Esch. coliNCTC 8007, serotype 0111
K58(B4)) a pathogenic Complement sensitive strain was pur-
chased from Health Protection Agency Culture Collections
(Health Protection Agency Culture Collections Porton
Down Salisbury Wiltshire, SP4 0JG UK). This strain was rou-
tinely grown in Luria-Bertani (LB) medium at 37 °C with
shaking. Standard LB broth and agar was prepared as
described Sambrook et al. (2001).
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Bactericidal sequestration assay
Esch. coli 0111 was prepared for overnight growth at 37 °C
on LB agar. An isolated colony from replicate plates
was inoculated into 3 tubes of LB broth (Merck KGaA,
Darmstadt,Germany) andgrownovernight at 37 °C. Theover-
night cultureswere centrifuged at 392 rcf, a pelletwas formed,
the supernatant was removed and the pellet was re-sus-
pended in phosphate buffer saline solution (1 × PBS solu-
tion) this step was repeated twice. On the final step the
pellet was suspended in LB broth and adjusted to 3 × 108
colony forming units (CFU) per ml using the McFarland
Method (Goldman et al. 1986). Using 96-well plates 3 × 20
μl of each of the three replicate cultures was added to each
round bottomed well (SARSTEDT Ltd, Wexford, Ireland) and
80 μl of the sample to be tested was then added. The plate
was incubated at 37 °C for 2 h shaking at 200 rpm (Model
Mini 4450 SHKA4450-1CE, Fischer Scientific, Ballycoolin,
Dublin). A 20 μl sample was taken from eachwell after the in-
cubation time and total viable counts enumerated on LB agar
using the pour plate method.
Serum susceptibility assay
The blood serum susceptibility assay developed by Hogan
et al. (1989) was adapted by substituting blood with milk.
Freshly collected bovine milk (125 μl) and heat treated milk
(control; 125 μl) were added to individual wells of a 96-well
plate, subsequently 100 μl Tris-NaCl2 buffer was added (1 ×
Sigma Chemical Company, St. Louis, MO). The next step
was the addition of 25 μl of the Esch. coli 0111 inoculum
which had been grown to a level of 106 CFU/ml. The 96-
well plate was incubated at 37 °C and viability of the bacteria
evaluated at 0 and 4 h.Viable bacteriawere platedonnutrient
agar (Merck KGaA, Darmstadt, Germany) for 15 h at 37 °C
and results were expressed in terms of differential growth
between the serum susceptibility assay and nutrient agar.
This was accomplished by subtracting the initial amount of
colonies (0 h) from the final number of viable colonies (4 h).
Results
Comparison of Complement-associated bactericidal activity
in bovine and human milks
The sequestration assay relies on the specific sensitivity of
Esch. coli 0111 to the presence of Complement, thus, an
active Complement system in milk would be expected to
retard growth of the strain. Furthermore, since Complement
is known to be inactivated at temperatures >56 °C for
30 min (Korhonen et al. 2000a) it is, thus, possible to
compare growth of Esch. coli 0111 in heated v. raw milk –
the differential in growth rates between the heated (control)
and raw milks being attributable to Complement activity.
This was evident when comparing the growth of Esch. coli in
heat-treated (56 °C, 30 min) milk, freshly collected raw
bovine milk and human milk (Fig. 1) where differential
counts after 2 h incubation at 37 °C were 6·32, 6·20 and
6·06 viable colonies of Esch. coli 0111 (log CFU/ml),
respectively – the lower value indicating a more effective
Complement response. This corresponded to cell reduction
factors of 0·12 and 0·26 (P < 0·01) following incubation with
raw bovine milk and human milk, respectively. Following
analysis for normality it was determined that a Kruskal–
Wallis test should be applied to the differential data, the
results of which confirmed that there was a statistical differ-
ence (P < 0·01) between all three samples, which was sup-
ported further by a Mann–Whitney test to show that both
raw bovine milk and human milk were significantly different
(P < 0·01) from the control (heat-treated milk).
Growth characteristics of Esch. coli 0111
The growth characteristics of Esch. coli 0111 was compared
by incubating the strain separately in nutrient broth or
bovine milk overnight at 37 °C in order to have an improved
understanding of its vitality during deployment in the
bactericidal sequestration assay.
The Esch. coli 0111 strain grew steadily on nutrient agar
starting from an initial viable colony count of 7·18 to reach
∼8·98 log CFU/ml after 24 h incubation (Fig. 2). Growth of
the strain in bovine milk peaked at 8·56 log CFU/ml at 13 h
during the same period after which it declined slightly.
Complement activity was also evident when Esch. coli
was inhibited in untreated wells during a serum susceptibil-
ity assay of forewarmed (56 °C, 30 min) and non-heated
bovine milk. The plated viable colonies reached peak
growth of 8·0 and 8·95 log cells/ml after incubation with
the raw bovine and heated bovine milks (control), respect-
ively (P < 0·05).
Investigation of Complement activity in cream separated
bovine milk
Preliminary laboratory work carried out on the variation
between freshly collected bovine milk and in-store
Fig. 1. Differential reduction in Esch. coli 0111 (log10 CFU/ml)
during bactericidal sequestration assay of (i) heated bovine milk
(control), (ii) raw bovine milk and (iii) human milk, after
inoculation and after 2 h incubation.
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purchased full-fat milk was extended to include low-fat
(1% fat) retail milks and skim milk prepared by cream separ-
ation in the laboratory from freshly collected raw bovine
milk (Fig. 3). Subsequent to assessment for normality, a
Kruskal–Wallis test revealed that there was a statistically sig-
nificant difference (P < 0·001) in colony forming units across
the five groups [control (heat inactivated milk), raw milk,
retailed full-fat milk, skim milk, retailed low-fat milk]. The
raw untreated bovine milk was more effective in inhibiting
growth of Esch. coli 0111 than the pasteurised sample.
The lower-fat milk variants (in-store purchased and lab-
prepared) were also less effective in reducing growth of
the Complement-sensitive strain. Further statistical analysis,
which examined individual groups (Mann–Whitney test),
confirmed that full fat raw milk was significantly different
from all other samples (P < 0·005).
Effect of fat reduction in human milk
Laboratory centrifugation (Patton & Huston, 1986) was used
to defat (remove the upper cream layer) human milk since
the available volume was too small for treatment by conven-
tional dairy cream separation technology.
Similar to bovine milk, the full-fat form of humanmilk was
significantly (P < 0·05) more effective than the defatted/
skimmed human milk (Fig. 4), thus confirming the associ-
ation between Complement and fat phase of the milks of
both species at a microstructure level.
Effect of heat treatment on Complement activity
The bactericidal sequestration assay was performed on
bovine milks which had been heated to each of the follow-
ing temperatures: 42, 45, 65, 72, 85 or 95 °C with holding for
10 min andcomparedwith that of bovinemilkheated to56 °C
for 30 min as control (Fig. 5). Maximum Complement activity
Fig. 3. Total viable counts of Esch. coli 0111 (log10 CFU/ml) after
2 h following incubation in (i) heated bovine milk (control), (ii) raw
bovine milk and (iii) retail pasteurised milk, (iv) raw bovine skim
milk, (v) retail pasteurised low fat milk during the bactericidal
sequestration assay for for 2 h at 37 °C.
Fig. 2. Total viable counts of Esch. coli 0111 (log10 CFU/ml)
during incubation at 37 °C for 24 h in nutrient broth and bovine
milk.
Fig. 4. Total viable counts of Esch. coli 0111 (log10 CFU/ml) after
2 h incubation in (i) heat treated bovine milk (control), (ii) lab
prepared skim human breast milk, (iii) human breast milk in
accordance with the bactericidal sequestration assay.
Fig. 5 Total viable counts of Esch. coli 0111 following 2 h
incubation in bovine milk heated at (i) 56 °C, 30 min (control), (ii)
42 °C, 10 min, (iii) 45 °C, 10 min, (iv) 65 °C, 10 min, (v) 72 °C,
10 min, (vi) 85 °C, 10 min, (vii) 95 °C, 10 min, in accordance
with bactericidal sequestration assay for 2 h, 37 °C.
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(5·41 log CFU/ml) was observed at 42 °C followed by a slight
loss (5·89 log CFU/ml) as the temperature increased to 45 °C.
Based on assay counts of 7·82–7·92 log CFU/ml, a sizeable
loss in Complement activity occurred when these milks
were heated to either 65 or 72 °C for 10 min (Fig. 5). At the
same time, the residual Complement activity associated with
the latter two temperatures falling within batch pasteurisation
(65 °C, 30 min) and continuous high temperature, short time
(HTST) holding conditions (72 °C, 15 s) concurs with its low
level presence in retailed, commercially pasteurised milks
referred to earlier. Further increases in temperature (85 or
95 °C for 10 min) continued to inactivate Complement. All
samples were significantly different from one another χ2
(6, n = 21) = 28·566, P < 0·001 (Fig. 5). Further post-hoc
comparisons using the Mann–Whitney test to look at indi-
vidual samples identified that there was no significant differ-
ence between 65 and 72 °C (P < 0·05).
Comparison of cream and buttermilk samples
Buttermilk is known to be rich in milk fat globule membrane
(MFGM) components (El-Loly, 2011). The Complement ac-
tivity of buttermilks was significantly (P < 0·05) greater than
that of the creams from which they were generated accord-
ing to the Kruskal Wallis test (Fig. 6). The buttermilk pre-
pared from the cream of raw milk was significantly
different (P < 0·01) from the laboratory-prepared cream,
retail cream and the washed buttermilk samples based on
the Mann–Whitney test of comparing each group individu-
ally A loss of bactericidal sequestration activity in the butter-
milks generated from washed cream would suggest that
Complement components were removed to some extent
into the aqueous phase.
Discussion
This study confirms that Ogundele’s (1998) bactericidal se-
questration assay which uses a specific strain of Esch. coli to
detect the presence of Complement activity in human milk
may now be extended for similar assay detection in
bovine milk. The bactericidal sequestration assay confirmed
the presence and activity of Complement in bovine milk,
this also suggests that both human and bovine milks are
broadly analogous in terms of their sequestration response
(Figs 1 & 4).
This is an interesting finding given the complexity of
Complement with its 30+ proteins and protein fragments
that there should be considerable homology between
human and bovine milks. Thus, the milks of both species
would appear to share the same amplifying Complement
cascade that builds up to the activation of a cell-killing
membrane attack complex (Ogundele, 2001). The results
in Fig. 1 – also highlight that the bactericidal sequestration
assay was adaptable to allow for the direct comparison of
human and bovine milk, thus making it possible to further
investigate various bovine milk by-product streams and
also milks subjected to different process treatments.
Exposure to a range of thermal treatments 42, 45, 65, 72, 85
and 95 °C for 10 min progressively inhibited Complement
activity (Fig. 5). The initial loss in Complement activity over
the course of a 3 °C rise during heating of bovine milk from
42 to 45 °C highlights how heat labile these immune proteins
are. Fortuitously, some residualComplement activity is still de-
tectable in and around typical milk pasteurisation tempera-
tures whether by batch heating or HTST methods. This
concurred also with assay results generated with samples
of commercially retailed pasteurised milks. Testing of fresh
untreated and retail pasteurised bovine milks in both full
and low fat variants provided the first indication that
Complement activity appeared to be greater in milks con-
taining a higher fat content (Fig. 3). This was confirmed in
the course of a follow-up study involving cream separation
of milk by either gravity-induced or centrifugally-employed
methods which showed that greater Complement activity
was detectable in the milk fat enriched phase of both
bovine and human milk Attempts at cream dilution to ascer-
tain if there was a relationship between Complement re-
sponse and fat content were not conclusive. This may
have been due to limitations with the microbiological
assay as a prozone-based inhibition effect has previously
been described (Rainard & Caffin, 1984; Ogundele, 2001).
In any case, Complement-based sequestration of Esch. coli
0111 was no longer observed in samples where milk fat
was depleted or substantially reduced in the case of raw
and retail low-fat milks. Simulated buttermaking of the pre-
pared creams enabled Complement activity to be tracked
during further partitioning between the fat and aqueous
(buttermilk) phases. Potent Complement activity evident in
buttermilk samples suggests that it most likely associates
with the MFGM components present. MFGM has already
been shown to exhibit some antibacterial properties
Fig. 6. Total viable counts of Esch. coli 0111 (log10 CFU/ml)
following 2 h incubation in (i) heated bovine milk, 56 °C, 30 min
(control), (ii) cream (∼40% fat) prepared from freshly collected
raw bovine milk (iii) retail pasteurised cream, (iv) lab prepared
buttermilk from cream of raw milk (v) lab prepared buttermilk
made from the cream (washed twice at 37 °C for 1 h) of raw
milk, after 2 h incubation at 37 °C according to the a bactericidal
sequestration assay.
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(Singh, 2006). MFGM as a tri-layer of both proteins and
lipids from the endoplasmic reticulum membrane and
mammary epithelium cells that envelopes the lipids in
milk (Mather, 1999) is also a carrier of biologically active
molecules like phospholipids, sphingolipids, cholesterol
and other bio-functional proteins (Lopez, 2011; Lopez
et al. 2011).
Overall, it can be seen that the Complement system is
present in bovine milk and while heat labile, a certain
amount of activity is detectable after milk pasteurisation.
Although not identical in response, the levels of Complement
activity in bovine milk are closely comparable with that of
human milk. Complement’s association with the fat phase of
milk has implications for the development of low fat variants
of fresh dairy products, and indeed where milk fat is replaced
by non-dairy fat sources in infant formula. Future studies
should aim to further investigate the factors that influence
Complement activity in bovine milk and methods to retain
its activity during processing.
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